Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more here.

Articles & Research
from hVIVO

Rolling Reviews – a useful tool to speed up the regulatory review process

Hot Topics – Vaccine Solutions for Tropical Diseases

Accelerated regulatory pathway for pandemic vaccines

ERS International Congress 2020 Presentation: Experimental Respiratory Syncytial Virus Infection in Adults 60-75 years

Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics

A Key Endpoint in Viral Challenge Models of Asthma Exacerbations

Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model

The Human Viral Challenge Model with A/PERTH/16/2009 H3N2A systematic analysis from five clinical studies

hVIVO is Gold Sponsor and presenter at World Vaccine Congress, Washington DC, USA April 2019

WVC 2017, 14-17 April 2019, Renaissance Washington DC Downtown Hotel, Washington DC, USA hVIVO is proud to once again be a Gold Sponsor of the World Vaccine Congress 2019, a...

hVIVO and Imutex Limited to present at IVW 2019 conference, Edinburgh, Scotland, April

Influenza Vaccines For The World 2019, April 02 - 04, Edinburgh, Scotland. hVIVO and its joint venture, Imutex Limited, will present at the Influenza Vaccines for the World (IVW 2019)...